↓ Skip to main content

Statin therapy in multimorbid older patients with polypharmacy- a cross-sectional analysis of the Swiss OPERAM trial population

Overview of attention for article published in Frontiers in Cardiovascular Medicine, September 2023
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (54th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter
5 X users

Readers on

mendeley
9 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Statin therapy in multimorbid older patients with polypharmacy- a cross-sectional analysis of the Swiss OPERAM trial population
Published in
Frontiers in Cardiovascular Medicine, September 2023
DOI 10.3389/fcvm.2023.1236547
Pubmed ID
Authors

Luise Adam, Oliver Baretella, Martin Feller, Manuel Raphael Blum, Dimitrios David Papazoglou, Benoit Boland, Drahomir Aujesky, Stéphanie Baggio, Nicolas Rodondi

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 9 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 1 11%
Professor > Associate Professor 1 11%
Student > Bachelor 1 11%
Lecturer 1 11%
Unknown 5 56%
Readers by discipline Count As %
Medicine and Dentistry 2 22%
Pharmacology, Toxicology and Pharmaceutical Science 1 11%
Unspecified 1 11%
Unknown 5 56%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 September 2023.
All research outputs
#15,289,600
of 24,710,887 outputs
Outputs from Frontiers in Cardiovascular Medicine
#2,079
of 8,622 outputs
Outputs of similar age
#128,848
of 293,036 outputs
Outputs of similar age from Frontiers in Cardiovascular Medicine
#59
of 472 outputs
Altmetric has tracked 24,710,887 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,622 research outputs from this source. They receive a mean Attention Score of 4.2. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 293,036 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 472 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.